Arbutus Biopharma (ABUS) Receivables - Other (2016 - 2018)
Arbutus Biopharma (ABUS) has disclosed Receivables - Other for 9 consecutive years, with $128000.0 as the latest value for Q1 2018.
- Quarterly Receivables - Other changed 0.0% to $128000.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $128000.0 through Mar 2018, changed 0.0% year-over-year, with the annual reading at $128000.0 for FY2017, 0.0% changed from the prior year.
- Receivables - Other hit $128000.0 in Q1 2018 for Arbutus Biopharma, roughly flat from $128000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $1.6 million in Q1 2015 to a low of $128000.0 in Q4 2015.
- Historically, Receivables - Other has averaged $291411.8 across 5 years, with a median of $128000.0 in 2015.
- Biggest five-year swings in Receivables - Other: surged 287.14% in 2015 and later plummeted 91.97% in 2016.
- Year by year, Receivables - Other stood at $538000.0 in 2014, then crashed by 76.21% to $128000.0 in 2015, then changed by 0.0% to $128000.0 in 2016, then changed by 0.0% to $128000.0 in 2017, then changed by 0.0% to $128000.0 in 2018.
- Business Quant data shows Receivables - Other for ABUS at $128000.0 in Q1 2018, $128000.0 in Q4 2017, and $128000.0 in Q3 2017.